Unlocking the potential of signature-based drug repurposing for anticancer drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Unlocking the potential of signature-based drug repurposing for anticancer drug discovery

Published:2024-11 Issue: Volume:761 Page:110150
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Biswal Sruti,Mallick Bibekanand^ORCID

Funder

University Grants Commission

Publisher

Elsevier BV

Reference166 articles.

1. World cancer report 2014;McGuire;Geneva, Switzerland: World Health Organization, international agency for research on cancer,2016

2. How to improve R&D productivity: the pharmaceutical industry's grand challenge;Paul,2010

3. Estimating the cost of new drug development: is it really $802 million?;Adams,2006

4. Drug repositioning: a brief overview;Jourdan;J. Pharm. Pharmacol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP